Risk of incident heart failure after COVID-19 recovery: a systematic review and meta-analysis.
COVID-19
Follow-up
Heart failure
Journal
Heart failure reviews
ISSN: 1573-7322
Titre abrégé: Heart Fail Rev
Pays: United States
ID NLM: 9612481
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
accepted:
12
12
2022
medline:
26
6
2023
pubmed:
27
12
2022
entrez:
26
12
2022
Statut:
ppublish
Résumé
Patients recovered from COVID-19 have an increased incidence of cardiovascular disease and heart structural changes. The aim of the present manuscript is to assess the risk of incident heart failure (HF) after COVID-19 infection. Data were obtained searching MEDLINE and Scopus for all studies published at any time up to September 1, 2022 reporting the risk of incident HF in COVID-19 recovered patients. The cumulative post-COVID-19 incidence and risk of incident HF were pooled using a random effects model and presented with the corresponding 95% confidence interval (CI). Statistical heterogeneity was measured using the Higgins I
Identifiants
pubmed: 36572763
doi: 10.1007/s10741-022-10292-0
pii: 10.1007/s10741-022-10292-0
pmc: PMC9792307
doi:
Types de publication
Meta-Analysis
Systematic Review
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
859-864Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Tobler DL, Pruzansky AJ, Naderi S, Ambrosy AP, Slade JJ (2022) Long-term cardiovascular effects of COVID-19: emerging data relevant to the cardiovascular clinician. Curr Atheroscler Rep 24:563–570
doi: 10.1007/s11883-022-01032-8
pubmed: 35507278
pmcid: 9065238
Izquierdo-Marquisá A, Cubero-Gallego H, Aparisi Á, Vaquerizo B, Ribas-Barquet N (2022) Myocardial injury in COVID-19 and its implications in short- and long-term outcomes. Front Cardiovasc Med 9:901245
doi: 10.3389/fcvm.2022.901245
pubmed: 35722133
pmcid: 9204594
Babapoor-Farrokhran S, Gill D, Walker J, Rasekhi RT, Bozorgnia B, Amanullah A (2020) Myocardial injury and COVID-19: Possible mechanisms. Life Sci 253:117723
doi: 10.1016/j.lfs.2020.117723
pubmed: 32360126
pmcid: 7194533
Metkus TS, Sokoll LJ, Barth AS, Czarny MJ, Hays AG, Lowenstein CJ, Michos ED, Nolley EP, Post WS, Resar JR, Thiemann DR, Trost JC, Hasan RK (2021) Myocardial injury in severe COVID-19 compared with non-COVID-19 acute respiratory distress syndrome. Circulation 143:553–565
doi: 10.1161/CIRCULATIONAHA.120.050543
pubmed: 33186055
Zuin M, Rigatelli G, Zuliani G, Bilato C, Zonzin P, Roncon L (2020) Incidence and mortality risk in coronavirus disease 2019 patients complicated by acute cardiac injury: systematic review and meta-analysis. J Cardiovasc Med (Hagerstown) 21:759–764
doi: 10.2459/JCM.0000000000001064
pubmed: 32740433
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 6:e1000097
doi: 10.1371/journal.pmed.1000097
Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P (2012) The Newcastle-Ottawa Scale (NOS) for assessing the quality if nonrandomized studies in meta-analyses. https://www.ohri.ca/programs/clinical_epidemiology/oxford.asp . Accessed 29 Aug 2022
Cohen K, Ren S, Heath K, Dasmariñas MC, Jubilo KG, Guo Y, Lipsitch M, Daugherty SE (2022) Risk of persistent and new clinical sequelae among adults aged 65 years and older during the post-acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 376:e068414
doi: 10.1136/bmj-2021-068414
pubmed: 35140117
Wang W, Wang CY, Wang SI, Wei JC (2022) Long-term cardiovascular outcomes in COVID-19 survivors among non-vaccinated population: a retrospective cohort study from the TriNetX US collaborative networks. EClinicalMedicine 53:101619
doi: 10.1016/j.eclinm.2022.101619
pubmed: 35971425
pmcid: 9366236
Xie Y, Xu E, Bowe B, Al-Aly Z (2022) Long-term cardiovascular outcomes of COVID-19. Nat Med 28:583–590
doi: 10.1038/s41591-022-01689-3
pubmed: 35132265
pmcid: 8938267
Salah HM, Fudim M, O’Neil ST, Manna A, Chute CG, Caughey MC (2022) Post-recovery COVID-19 and incident heart failure in the National COVID Cohort Collaborative (N3C) study. Nat Commun 13:4117
doi: 10.1038/s41467-022-31834-y
pubmed: 35840623
pmcid: 9284961
Daugherty SE, Guo Y, Heath K, Dasmariñas MC, Jubilo KG, Samranvedhya J, Lipsitch M, Cohen K (2021) Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ 373:n1098
doi: 10.1136/bmj.n1098
pubmed: 34011492
Lacny S, Wilson T, Clement F, Roberts DJ, Faris P, Ghali WA, Marshall DA (2018) Kaplan-Meier survival analysis overestimates cumulative incidence of health-related events in competing risk settings: a meta-analysis. J Clin Epidemiol 93:25–35
doi: 10.1016/j.jclinepi.2017.10.006
pubmed: 29045808
Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC (2020) COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nat Rev Cardiol 17:543–558
doi: 10.1038/s41569-020-0413-9
pubmed: 32690910
pmcid: 7370876
Carfì A, Bernabei R, Landi F (2020) Persistent symptoms in patients after acute COVID-19. JAMA 324:603–605
doi: 10.1001/jama.2020.12603
pubmed: 32644129
pmcid: 7349096
Bader F, Manla Y, Atallah B, Starling RC (2021) Heart failure and COVID-19. Heart Fail Rev 26:1–10
doi: 10.1007/s10741-020-10008-2
pubmed: 32720082
Cowie MR, Mourilhe-Rocha R, Chang HY, Volterrani M, Ban HN, Campos de Albuquerque D, Chung E, Fonseca C, Lopatin Y, Magaña Serrano JA, Mircheva L, Moncada-Paz GA, Pagava Z, Reyes EB, Saldarriaga C, Schwartzmann P, Sim Kheng Leng D, Trivi M, Yotov YT, Zieroth S, Heart Failure Care OPTIMIZE, program coordinators (2022) The impact of the COVID-19 pandemic on heart failure management: Global experience of the OPTIMIZE Heart Failure Care network. Int J Cardiol 363:240–246
doi: 10.1016/j.ijcard.2022.06.022
pubmed: 35750302
pmcid: 9217066
Zhang HG, Dagliati A, Shakeri Hossein Abad Z, Xiong X, Bonzel CL, Xia Z, Tan BWQ, Avillach P, Brat GA, Hong C, Morris M, Visweswaran S, Patel LP, Gutiérrez-Sacristán A, Hanauer DA, Holmes JH, Samayamuthu MJ, Bourgeois FT, L’Yi S, Maidlow SE, Moal B, Murphy SN, Strasser ZH, Neuraz A, Ngiam KY, Loh NHW, Omenn GS, Prunotto A, Dalvin LA, Klann JG, Schubert P, Vidorreta FJS, Benoit V, Verdy G, Kavuluru R, Estiri H, Luo Y, Malovini A, Tibollo V, Bellazzi R, Cho K, Ho YL, Tan ALM, Tan BWL, Gehlenborg N, Lozano-Zahonero S, Jouhet V, Chiovato L, Aronow BJ, Toh EMS, Wong WGS, Pizzimenti S, Wagholikar KB, Bucalo M; Consortium for clinical characterization of COVID-19 by EHR (4CE), Cai T, South AM, Kohane IS, Weber GM (2022) International electronic health record-derived post-acute sequelae profiles of COVID-19 patients. NPJ Digit Med 5:81
doi: 10.1038/s41746-022-00623-8
Sidik SM (2022) Heart disease after COVID: what the data say. Nature 608:26–28
doi: 10.1038/d41586-022-02074-3
pubmed: 35918523
Cozzolino F, Montedori A, Abraha I, Eusebi P, Grisci C, Heymann AJ, Lombardo G, Mengoni A, Orso M, Ambrosio G (2019) A diagnostic accuracy study validating cardiovascular ICD-9-CM codes in healthcare administrative databases. The Umbria Data-Value Project PLoS One 14:e0218919
doi: 10.1371/journal.pone.0218919
pubmed: 31283787
Delekta J, Hansen SM, AlZuhairi KS, Bork CS, Joensen AM (2018) The validity of the diagnosis of heart failure (I50.0-I50.9) in the Danish National Patient Register. Dan Med J 65:A5470
Greene SJ, Lautsch D, Yang L, Tan XI, Brady JE (2022) Prognostic interplay between COVID-19 and heart failure with reduced ejection fraction. J Card Fail 28:1287–1297
doi: 10.1016/j.cardfail.2022.05.001
pubmed: 35597512
pmcid: 9116978